KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Assets (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Current Assets data on record, last reported at $1.4 billion in Q4 2025.

  • For Q4 2025, Current Assets rose 1.0% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 1.0%, while the annual FY2025 figure was $1.4 billion, 1.0% up from the prior year.
  • Current Assets reached $1.4 billion in Q4 2025 per IDXX's latest filing, up from $1.4 billion in the prior quarter.
  • Across five years, Current Assets topped out at $1.5 billion in Q2 2024 and bottomed at -$1.7 billion in Q2 2023.
  • Average Current Assets over 5 years is $917.9 million, with a median of $1.2 billion recorded in 2023.
  • Peak YoY movement for Current Assets: soared 190.36% in 2024, then decreased 10.88% in 2025.
  • A 5-year view of Current Assets shows it stood at $955.7 million in 2021, then rose by 15.26% to $1.1 billion in 2022, then soared by 35.75% to $1.5 billion in 2023, then decreased by 6.38% to $1.4 billion in 2024, then grew by 1.0% to $1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $1.4 billion in Q4 2025, $1.4 billion in Q2 2025, and $1.3 billion in Q1 2025.